Skip to main navigation Skip to search Skip to main content

IMMU-18. IMMUNOGENOMIC RESPONDER PHENOTYPE FROM A PHASE I TRIAL OF ANTI-LAG3 OR ANTI-CD137 ALONE AND IN COMBINATION WITH ANTI-PD-1 IN PATIENTS WITH RECURRENT GBM

  • Christina Jackson
  • , John Choi
  • , JiaJia Zhang
  • , Anna Piotrowski
  • , Tobias Walbert
  • , Arati Desai
  • , Manmeet Ahluwalia
  • , Burt Nabors
  • , Xiaobu Ye
  • , Serena Desideri
  • , Joy Fisher
  • , Patrick Wen
  • , Stuart Grossman
  • , Kellie Smith
  • , Drew Pardoll
  • , Michael Lim

Research output: Contribution to conferencePresentation

Original languageAmerican English
DOIs
StatePublished - Nov 11 2019
EventNeuro-oncology -
Duration: Nov 11 2019 → …

Conference

ConferenceNeuro-oncology
Period11/11/19 → …

Disciplines

  • Medicine and Health Sciences
  • Oncology

Cite this